Target intelligence / Profile preview

Mediator complex subunit 12-like protein (MED12L)

Target
MED12L
Molecular classification
Transcription factor complex subunit, Other (Mediator complex component), Nuclear protein
01

Overview

Mediator complex subunit 12-like protein (MED12L) is a subunit of the Mediator kinase module, a multi-protein complex that acts as a coactivator for RNA polymerase II-dependent transcription in almost all eukaryotes[1][2][5]. As part of this module, MED12L helps relay signals from gene-specific regulators to the basal transcription machinery and is important for the regulation of gene expression during development, especially in the nervous system[1][5]. Genetic variants causing loss of function in MED12L are associated with intellectual disability, developmental delay, and speech impairment, sometimes accompanied by behavioral abnormalities and mild facial differences[1]. MED12L is highly expressed in the brain and is predicted to share domain homology with MED12, including roles in Wnt/beta-catenin pathway activation[1]. While key to fundamental transcriptional processes, MED12L is not currently considered a therapeutic target or site of known drug interaction[1][5].

Other names
Mediator of RNA polymerase II transcription subunit 12-like proteinKIAA1635TNRC11LTRALPTRALPUSHPRO0314Mediator complex subunit 12-like proteinThyroid hormone receptor-associated-like proteinTrinucleotide repeat-containing gene 11 protein-likeNIZIDSNOPARNo opposite paired repeat protein
02

Biological functions

Transcriptional coactivator of RNA polymerase II-dependent genesGene expression regulationNeural development and differentiationCell growth and homeostasis
03

Disease associations

Neurodevelopmental disorder (including intellectual disability, developmental delay)Speech impairmentAutism spectrum disorder (reported in cases)Minor contribution to other disorders via disruption of transcription (evidence largely in neurological context)
04

Safety considerations

Variants can cause neurodevelopmental disorders and intellectual disability via haploinsufficiency[1].

Beyond the preview

Go deeper on Mediator complex subunit 12-like protein (MED12L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mediator complex subunit 12-like protein (MED12L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call